Computerized reminders to monitor liver function to improve the use of etretinate

International Journal of Medical Informatics

Volumn 57, Issue 1, 2000, Pages 11-19

  Koide, Daisuke ^a   Ohe, Kazuhiko ^b   Ross Degnan, Dennis ^c   Kaihara, Shigekoto ^d  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^c 126 Brookline Avenue Suite 200 ^*  (United States)

^d National Okura Hospital   (Japan)

Author keywords

Computerized alert; Drug utilization; Hospital computer system; Intervention; Quality of care

Indexed keywords

DRUG PRODUCTS; ENZYMES; HEALTH CARE;

HOSPITAL COMPUTER SYSTEM;

MEDICAL COMPUTING;

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; ETRETINATE;

ARTICLE; COMPUTER SYSTEM; DRUG MONITORING; DRUG USE; HEALTH CARE QUALITY; HUMAN; INFORMATION SYSTEM; LIVER FUNCTION; LIVER TOXICITY; PRESCRIPTION; PRIORITY JOURNAL;

COMPUTER COMMUNICATION NETWORKS; ETRETINATE; FEMALE; HUMANS; KERATOLYTIC AGENTS; LIVER DISEASES; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PRESCRIPTIONS, DRUG; QUALITY OF HEALTH CARE; REMINDER SYSTEMS;

EID: 0033956396     PISSN: 13865056     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-5056(99)00055-6     Document Type: Article

References (58)

1. Classen D.C., Pestotnik S.L., Evans R.S., Burke J.P. Computerized surveillance of adverse drug events in hospital patients. J. Am. Med. Assoc. 266:1991;2847-2851.
2. Classen D.C., Pestotnik S.L., Evans R.S., Lloyd J.F., Burke J.P. Adverse drug events in hospitalized patients: excess length of stay, extra costs, and attributable mortality. J. Am. Med. Assoc. 277:1997;301-306.
3. Brennan T.A., Leape L.L., Laird N.M., Hebert L., Localio A.R., Lawthers A.G., Newhouse J.P., Weiler P.C., Hiatt H.H. Incidence of adverse events and negligence in hospitalized patients: results from the Harvard Medical Practice Study I. N. Engl. J. Med. 324:1991;370-376.
4. Leape L.L., Brennan T.A., Laird N., Lawthers A.G., Localio A.R., Barnes B.A., Hebert L., Newhouse J.P., Weiler P.C., Hiatt H. The nature of adverse events in hospitalized patients: results from the Harvard Medical Practice Study II. N. Engl. J. Med. 324:1991;377-384.
5. Porter J., Jick H. Drug-related deaths among medical inpatients. J. Am. Med. Assoc. 237:1977;879-881.
6. Ferner R.E., Whittington R.M. Coroner's cases of death due to errors in prescribing or giving medicines or to adverse drug reactions: Birmingham 1986-1991. J. R. Soc. Med. 87:1994;145-148.
7. Ferner R.E. Is there a cure for drug errors? Br. Med. J. 311:1995;463-464.
8. Bates D.W., Spell N., Cullen D.J., Burdick E., Laird N., Petersen L.A., Small S.D., Sweitzer B.J., Leape L.L. For the Adverse Drug Events Prevention Study Group: the costs of adverse drug events in hospitalized patients. J. Am. Med. Assoc. 277:1997;307-311.
9. Bates D.W., Leape L.L., Petrycki S. Incidence and preventability of adverse drug events in hospitalized adults. J. Gen. Intern. Med. 8:1993;289-294.
10. Bates D.W., Boyle D.L., Vander Vliet M.B., Schneider J., Leape L.L. Relationship between medication errors and adverse drug events. J. Gen. Intern. Med. 10:1995;199-205.
11. Leape L.L., Bates D.W., Cullen D.J., Cooper J., Demonaco H.J., Gallivan T., Hallisey R., Ives J., Laird N., Laffel G., Nemeskal R., Petersen A.L., Porter K., Servi D., Shea F.B., Small D.S., Sweitzer J.B., Thompson B.T., Vander Vliet M. Systems analysis of adverse drug events. J. Am. Med. Assoc. 274:1995;35-43.
12. Dartnell J.G., Anderson R.P., Chohan V., Galbraith K.J., Lyon M.E., Nestor P.J., Moulds R.F. Hospitalisation for adverse events related to drug therapy: incidence, avoidability and costs. Med. J. Aust. 164:1996;659-662.
13. Nelson K.M., Talbert R.L. Drug-related hospital admissions. Pharmacotherapy. 16:1996;701-707.
14. Bates D.W. Medication errors: how common are they and what can be done to prevent them? Drug Saf. 15:1996;303-310.
15. Lesar T.S., Briceland L., Stein D.S. Factors related to errors in medication prescribing. J. Am. Med. Assoc. 277:1997;312-317.
16. McDonald C.J. Protocol-based computer reminders, quality of care and the nonperfectability of man. N. Engl. J. Med. 295:1976;1351-1355.
17. McDonald C.J. Use of a computer to detect and respond to clinical events: its effect on clinician behavior. Ann. Intern. Med. 84:1976;162-167.
18. McDonald C.J., Wilson G.A., McCabe G.P. Jr Physician response to computer reminders. J. Am. Med. Assoc. 244:1980;1579-1581.
19. Young D.W. Improving the consistency with which investigations are requested. Med. Inf. 6:1981;13-17.
20. Barnett G.O., Winickoff R.N., Morgan M.M., Zielstorff R.D. A computer-based monitoring system for follow-up of elevated blood pressure. Med. Care. 21:1983;400-409.
21. McDonald C.J., Hui S.L., Smith D.M., Tierney W.M., Cohen S.J., Weinberger M., McCabe G.P. Reminders to physicians from an introspective computer medical record. A two-year randomized trial. Ann. Intern. Med. 100:1984;130-138.
22. White K.S., Lindsay A., Pryor T.A., Brown W.F., Walsh K. Application of a computerized medical decision-making process to the problem of digoxin intoxication. J. Am. Coll. Cardiol. 4:1984;571-576.
23. Tierney W.M., Hui S.L., McDonald C.J. Delayed feedback of physician performance versus immediate reminders to perform preventive care. Effects on physician compliance. Med. Care. 24:1986;659-666.
24. Tierney W.M., McDonald C.J., Hui S.L., Martin D.K. Computer predictions of abnormal test results. Effects on outpatient testing. J. Am. Med. Assoc. 259:1988;1194-1198.
25. McDowell I., Newell C., Rosser W. Computerized reminders to encourage cervical screening in family practice. J. Fam. Pract. 28:1989;420-424.
26. McPhee S.J., Bird J.A., Fordham D., Rodnick J.E., Osborn E.H. Promoting cancer prevention activities by primary care physicians: results of a randomized, controlled trial. J. Am. Med. Assoc. 266:1991;538-544.
27. McDonald C.J., Hui S.L., Tierney W.M. Effects of computer reminders for influenza vaccination on morbidity during influenza epidemics. MD Comput. 9:1992;304-312.
28. Litzelman D.K., Dittus R.S., Miller M.E., Tierney W.M. Requiring physicians to respond to computerized reminders improves their compliance with preventive care protocols. J. Gen. Intern. Med. 8:1993;311-317.
29. Burack R.C., Gimotty P.A., George J., Stengle W., Warbasse L., Moncrease A. Promoting screening mammography in inner-city settings: a randomized controlled trial of computerized reminders as a component of a program to facilitate mammography. Med. Care. 32:1994;609-624.
30. Johnston M.E., Langton K.B., Haynes R.B., Mathieu A. Effects of computer-based clinical decision support systems on clinician performance and patient outcome. A critical appraisal of research. Ann. Intern. Med. 120:1994;135-142.
31. Rind D.M., Safran C., Phillips R.S., Wang Q., Calkins D.R., Delbanco T.L., Bleich H.L., Slack W.V. Effect of computer-based alerts on the treatment and outcomes of hospitalized patients. Arch. Intern. Med. 154:1994;1511-1517.
32. Chase C.R., Vacek P.M., Shinozaki T., Giard A.M., Ashikaga T. Medical information management: improving the transfer of research results to presurgical evaluation. Med. Care. 21:1983;410-424.
33. Rodman J.H., Jelliffe R.W., Kolb E., Tuey D.B., de Guzman M.F., Wagers P.W., Haywood L.J. Clinical studies with computer-assisted initial lidocaine therapy. Arch. Intern. Med. 144:1984;703-709.
34. Whiting-O'Keefe Q.E., Simborg D.W., Epstein W.V., Warger A. A computerized summary medical record system can provide more information than the standard medical record. J. Am. Med. Assoc. 254:1985;1185-1192.
35. White R.H., Hong R., Venook A.P., Daschbach M.M., Murray W., Mungall D.R., Coleman R.W. Initiation of warfarin therapy: comparison of physician dosing with computer-assisted dosing. J. Gen. Intern. Med. 2:1987;141-148.
36. Gonzalez E.R., Vanderheyden B.A., Ornato J.P., Comstock T.G. Computer-assisted optimization of aminophylline therapy in the emergency department. Am. J. Emerg. Med. 7:1989;395-401.
37. McDonald C.J., Tierney W.M., Overhage J.M., Martin D.K., Wilson G.A. The Regenstrief Medical Record System: 20 years of experience in hospitals, clinics, and neighborhood health centers. MD Comput. 9:1992;206-217.
38. Tierney W.M., Overhage J.M., Takesue B.Y., Harris L.E., Murray M.D., Vargo D.L., McDonald C.J. Computerizing guidelines to improve care and patient outcomes: the example of heart failure. J. Am. Med. Assoc. 2:1995;316-322.
39. Wilson G.A., McDonald C.J., McCabe G.P. The effect of immediate access to a computerized medical record on physician test ordering: a controlled clinical trial in the emergency room. Am. J. Pub. Health. 72:1982;698-702.
40. Hershey C.O., Porter D.K., Breslau D., Cohen D.I. Influence of simple computerized feedback on prescription charges in an ambulatory clinic. A randomized clinical trial. Med. Care. 24:1986;472-481.
41. Tierney W.M., McDonald C.J., Martin D.K., Hui S.L., Rogers M.P. Computerized display of past test results: effects on outpatient testing. Ann. Intern. Med. 107:1987;569-574.
42. Tierney W.M., Miller M.E., McDonald C.J. The effect on test ordering of informing physicians of the charges for outpatient diagnostic tests. N. Engl. J. Med. 233:1990;1499-1504.
43. Tierney W.M., Miller M.E., Overhage J.M., McDonald C.J. Physician inpatient order writing on microcomputer workstations. Effects on resource utilization. J. Am. Med. Assoc. 269:1993;379-383.
44. Physicians' Desk Reference, 49th ed., Medical Economics Data, Montvale, 1995.
45. USPDI Drug information for the health care professional, 15th ed., United States Pharmacopeial Convention, Rockville, 1995.
46. Roenigk H.H. Jr Retinoids. Effect on the liver. Saurat J.H. Retinoids: New Trends in Research and Therapy. 1:1984;476-488 Karger, Basel.
47. Weiss V.C., Layden T., Spinowitz A., Buys C.M., Nemchausky B.A., West D.P., Emmons K.M. Chronic active hepatitis associated with etretinate therapy. Br. J. Dermatol. 112:1985;591-597.
48. Ellis C.N., Voorhees J.J. Etretinate therapy. J. Am. Acad. Dermatol. 16:1987;267-291.
49. Fallon M.B., Boyer J.L. Hepatic toxicity of vitamin A and synthetic retinoids. J. Gastroenterol. Hepatol. 5:1990;334-342.
50. Halioua B., Saurat J.H. Risk benefit ratio in the treatment of psoriasis with systemic retinoid. Br. J. Dermatol. 122:1990;135-150.
51. Sanchez M.R., Ross B., Rotterdam H., Salik J., Brodie R., Freedberg M. Retinoid hepatitis. J. Am. Acad. Dermatol. 28:1993;853-858.
52. Nippon Roche, Tigason capsule 10 capsule 25. Interview form for Ethical Drugs, 5th ed., Nippon Roche, Tokyo, 1995.
53. C.S. Davidson, C.M. Leevy, E.C. Chamberlayne Guideline for detection of hepatotoxicity due to drugs and chemicals, NIH publication No.79-313, Washington DC, 1979, pp. 108-110.
54. Soumerai S.B., Lipton H.L. Evaluating and improving physician prescribing. Strom B.L. Pharmacoepidemiology. 2nd ed. 1994;395-412 Wiley, Chichester.
55. Naranjo C.A., Busto U., Sellers E.M., Sandor P., Ruiz I., Roberts E.A., Janecek E., Domecq C., Greenblatt D.J. A method for estimating the probability of adverse drug reactions. Clin. Pharmacol. Ther. 30:1981;239-245.
56. Kramer M.S., Leventhal J.M., Hutchinson T.A., Feinstein A.R. An algorithm for the operational assessment of adverse drug reactions I: background, description, and instructions for use. J. Am. Med. Assoc. 242:1979;623-632.
57. Karch F.E., Lasagna L. Toward the operational identification of adverse drug reactions. Clin. Pharmacol. Ther. 21:1977;247-254.
58. Venulet J., Ciucci A.G., Berneker G.C. Updating of a method for causality assessment of adverse drug reactions. Int. J. Clin. Pharmacol. Ther. Toxicol. 24:1986;559-568.